e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Pulmonary circulation: clinical databases and registries
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary hypertension in patients with lupus: Prevalence, etiology and risk factors
F. León, G. Pérez-Peñate, J. Navarro, G. Juliá, A. García, C. Cabrera, P. Cabrera, N. Ojeda, J. Pulido, I. Rúa Figueroa (Las Palmas de Gran Canaria, Spain)
Source:
Annual Congress 2012 - Pulmonary circulation: clinical databases and registries
Session:
Pulmonary circulation: clinical databases and registries
Session type:
Oral Presentation
Number:
367
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. León, G. Pérez-Peñate, J. Navarro, G. Juliá, A. García, C. Cabrera, P. Cabrera, N. Ojeda, J. Pulido, I. Rúa Figueroa (Las Palmas de Gran Canaria, Spain). Pulmonary hypertension in patients with lupus: Prevalence, etiology and risk factors. Eur Respir J 2012; 40: Suppl. 56, 367
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Should we screen for hereditary pulmonary hypertension?
Related content which might interest you:
Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival
Source: Eur Respir J 2013; 42: 1271-1282
Year: 2013
Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis
Source: Eur Respir J, 51 (4) 1701197; 10.1183/13993003.01197-2017
Year: 2018
Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2009; 33: 325-331
Year: 2009
Prevalence of pulmonary hypertension in patients with plasma lupus anticoagulant
Source: Eur Respir J 2006; 28: Suppl. 50, 406s
Year: 2006
Early outcomes of patients with systemic lupus erythematosus and antiphospholipid syndrome after pulmonary endarterectomy
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016
Thrombophilia in patients with idiopathic pulmonary thromboembolism vs associated with risk factors
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
Source: Eur Respir J 2011; 37: 356
Year: 2011
Prevalence, risk factors and prognosis of pulmonary hypertension in cystic fibrosis
Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Year: 2011
Presence of inherited risk factors in patients with pulmonary thromboembolism (PTE)
Source: Eur Respir J 2005; 26: Suppl. 49, 521s
Year: 2005
Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening
Source: Eur Respir Rev 2011; 20: 270-276
Year: 2011
The frequency of chronic thromboembolic pulmonary hypertension and associated risk factors
Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism
Year: 2011
Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
The prevalence of pulmonary hypertension and the related factors in hemodialysis patients
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012
Thrombophilic risk factors for chronic thromboembolic pulmonary hypertension (CTEPH) in Korea
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015
The prevalence and affecting factors of pulmonary hypertension in hemodialysis patients
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Prevalence and associated factors of osteoporosis among patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2012; 21: 27-31
Year: 2012
Risk assessment in scleroderma patients with newly diagnosed pulmonary arterial hypertension: application of the ESC/ERS risk prediction model
Source: Eur Respir J, 52 (4) 1800497; 10.1183/13993003.00497-2018
Year: 2018
Pulmonary hypertension in COPD: Prevalence and characteristics
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012
Severe pulmonary sarcoidosis: definition and risk stratification
Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ?
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept